Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Portfolio Pulse from Benzinga Newsdesk
Venus Concept Inc. announced it has received Israeli regulatory approval for Venus Bliss MAX, a medical aesthetic technology. The product was first launched in the U.S. in Q1 2022 after FDA clearance and is available in approved jurisdictions internationally.
April 08, 2024 | 11:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Venus Concept Inc. received Israeli regulatory approval for Venus Bliss MAX, enhancing its product availability internationally.
Receiving regulatory approval in a new market like Israel significantly expands the potential customer base for Venus Bliss MAX, potentially boosting Venus Concept's revenue and market presence. This development is likely to be viewed positively by investors, potentially leading to a short-term uptick in VERO's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100